CHI Advisors’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $13M | Buy |
|
|||||
|
2023
Q2 | $16.2M | Buy |
|
|||||
|
2023
Q1 | $11.1M | Buy |
|
|||||
|
2022
Q4 | $10.3M | Buy |
|
|||||
|
2022
Q3 | $7.53M | Buy |
|
|||||
|
2022
Q2 | $2.86M | Buy |
|
|||||
|
2022
Q1 | $3.38M | Buy |
|
|||||
|
2021
Q4 | $1.02M | Buy |
|
|||||
|
2021
Q3 | $500K | Sell |
|
|||||
|
2021
Q2 | $4.94M | Sell |
|
|||||
|
2021
Q1 | $24.6M | Sell |
|
|||||
|
2020
Q4 | $30.6M | Sell |
|
|||||
|
2020
Q3 | $22M | Sell |
|
|||||
|
2020
Q2 | $21.7M | Buy |
|